Shannon Campbell's most recent trade in Black Diamond Therapeutics Inc was a trade of 30,550 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 4,500 | 8,865 (0%) | 0% | 2.5 | 11,250 | Common Stock |
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 2,354 | 4,365 (0%) | 0% | 4.8 | 11,252 | Common Stock |
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,011 | 2,011 (0%) | 0% | 5.0 | 10,015 | Common Stock |
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 61,100 | 61,100 | - | - | Stock Option (Right to Buy) |